DIN 02443074 — OFEV 150 MG
OFEV is a capsule of Nintedanib marketed by BOEHRINGER INGELHEIM (CANADA) LTD LTEE. The full Nintedanib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02443074
- Brand name
- OFEV
- Active ingredient
- Nintedanib
- Strength
- 150 MG
- Dosage form
- CAPSULE
- Route
- ORAL
- Manufacturer
- BOEHRINGER INGELHEIM (CANADA) LTD LTEE
- Health Canada status
- MARKETED
- Drug class
- Protein kinase inhibitor (anti-fibrotic agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Nintedanib products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02526891 | AURO-NINTEDANIB | 100 MG | CAPSULE | AURO PHARMA INC | MARKETED |
| 02526905 | AURO-NINTEDANIB | 150 MG | CAPSULE | AURO PHARMA INC | MARKETED |
| 02550849 | JAMP NINTEDANIB | 100 MG | CAPSULE | JAMP PHARMA CORPORATION | MARKETED |
| 02540762 | JAMP NINTEDANIB | 150 MG | CAPSULE | JAMP PHARMA CORPORATION | MARKETED |
| 02443066 | OFEV | 100 MG | CAPSULE | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | MARKETED |